期刊文献+

二甲双胍对晚期糖基化终产物诱导的血管平滑肌细胞增殖的影响

Effects of metformin on the proliferation of vascular smooth muscle cells induced by advanced glycation end products
下载PDF
导出
摘要 目的:观察晚期糖基化终产物(advanced glycation endproducts,AGEs)对血管平滑肌细胞(vascular smooth muscle cells,VSMCs)增殖的影响及二甲双胍的干预作用。方法:生长状态良好的VSMCs,用不同浓度的AGEs(50、100、200、400 mg/L)干预细胞不同时间(12、24、48、72 h);不同浓度的二甲双胍(10-3,10-4,5×10-5,10-5,10-6mol/L)与200 mg/L AGEs共干预不同时间(12、24、48、72 h),MTT法测定VSMCs增殖。结果:50 mg/L AGEs干预72 h时表现出促进增殖的作用,200 mg/L AGEs干预12 h即有增殖促进作用,24 h时作用最强,400 mg/L AGEs各时间点作用同200 mg/LAGEs组;10-3与10-4mol/L二甲双胍干预24 h抑制作用最强,持续到72 h,10-6mol/L抑制增殖作用降低,24 h起效,72 h时仍有作用。结论:AGEs呈浓度和时间依赖性地促进VSMCs增殖;二甲双胍可抑制AGEs诱导的VSMCs增殖作用。 AIM:To observe the effects of advanced glycation end products on the proliferation of vascular smooth muscle cells(VSMCs) and how the course are interfered with metformin. METHODS: Well-conditioned VSMCs were dealed with different concentrations of advanced glycation end products(50,100,200,400 mg/L) in different times(12,24,48,72 h).On the basis of above treatments,different concentrations of metformin(10-3,10-4,5×10-5,10-5,10-6 mol/L) were given to interfere VSMCs,combined with the 200 mg/L AGEs on different times(12,24,48,72 h).The proliferation of VSMCs was measured by MTT.RESULTS:50 mg/L AGEs could promote the proliferation of VSMCs at the time point of 72 h;200 mg/L AGEs began to play the role of promotion at the time point of 12 h,furthermore,24 h were the strongest.The effects of 400 mg/L AGEs was similar to those of 200 mg/L AGEs at all the time points.10-3 mol/L and 10-4 mol/L metformin had the strongest effects of inhibition at the time point of 12 h,and this effect continued to 72 h.10-6 mol/L metformin had lower inhibition on proliferation and its effective time was from 24 h to 72 h.CONCLUSION: AGEs can promote the proliferation of vascular smooth muscle cells in a concentration-and time-dependent manner;metformin can inhibit the proliferation of vascular smooth muscle cells induced by AGEs.
出处 《中国临床药理学与治疗学》 CAS CSCD 2010年第12期1368-1372,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 二甲双胍 晚期糖基化终产物 细胞增殖 Metformin Advanced glycation end products Cell proliferation
  • 相关文献

参考文献13

  • 1Jandel Eit-Dahm K, Watson A, Soro-Paavonen A. The AGE/RAGE axis in diabetes accelerated atherosclerosis [J]. Clin Exp Pharmacol Physiol, 2008 , 35(3) :329-334.
  • 2Kaneda H, Taguchi J, Ogasawara K, et al. Increased level of advanced oxidation protein products in patients with coronary artery disease[J]. Atherosclerosis, 2002,162 (1) : 221 - 225.
  • 3张卫茹,侯凡凡,刘尚喜,郭志坚,周展眉,王国保,富宁,刘志强,王力,周玫.晚期糖基化终产物通过氧化应激加速动脉粥样硬化斑块形成[J].中华医学杂志,2004,84(13):1066-1070. 被引量:28
  • 4Goldin A, Beckman JA, Schmidt AM, et al. Ad vanced glycation end products sparking the development of diabetic vascular injury [J]. Circulation, 2006, 114(6) :597-605.
  • 5袁晓晨,刘乃丰,张昕.吡格列酮和厄贝沙坦对糖基化终产物诱导血管平滑肌细胞增殖的影响[J].中国新药与临床杂志,2006,25(7):501-504. 被引量:6
  • 6American Diabetes Association. Standards of medical care in diabetes-2008 [J]. Diabetes Care, 2008, 31(Suppl 1) :S12--S54.
  • 7Lund SS, Tarnow L, Frandsen M, et al. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in nonobese patients with type 2 dia betes [J]. Eur J Endocrinol, 2008,158 (1):35- 46.
  • 8Kitabchi AE, Temprosa M, Knowler WC, et al. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program., effects of lifestyle intervention and met formin[J]. Diabetes, 2005, 54 (8) : 2404--2414.
  • 9Isoda K, Young JL, Zirlik A,et al. Metformin in hibits proinflammatory responses and nuclear factor- kappaB in human vascular wall cells [J]. Arterioscler Thromb Vasc Biol,2006,26(3) :611-617.
  • 10Gomez-Garcia A, Martinez Torres G, Ortega-Pierres LE. Rosuvastatin and metformin decrease inflammation and oxidative stress in patients with hypertension and dyslipidemia[J]. Rev Esp Cardiol, 2007, 60(12) :1242--1249.

二级参考文献27

  • 1陈燕铭,曾龙驿,吴伟康,罗汉川,张国超,刘筱蔼,颜建云,钱孝贤.厄贝沙坦对糖尿病大鼠丙二醛和超氧化物歧化酶的影响[J].中国新药与临床杂志,2004,23(9):592-595. 被引量:11
  • 2胡榕,吴可贵.凝血酶及其受体在血管平滑肌细胞增殖中的作用[J].高血压杂志,2004,12(4):283-286. 被引量:4
  • 3胡榕,吴可贵.核因子κB在心血管疾病中的作用的研究现状[J].中国动脉硬化杂志,2004,12(5):604-606. 被引量:17
  • 4申洪,陆药丹.免疫组织化学染色的定量方法研究[J].生物医学工程学杂志,1993,10(4):281-284. 被引量:126
  • 5ASO Y, INUKAI T, TAYAMA K, et al. Serum concentrations of advanced glycation end products are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes[J]. Acta Diabetol, 2000,37 (2) : 87-92.
  • 6LAW RE, GOETZE S, XI XP, et al. Expression and function of PPAR gamma in rat and human vascular smooth muscle cells[J].Circulation, 2000,101 (11) : 1311-1320.
  • 7MIYATA T, STRIHOU C,UEDA Y, et al. Angiotensin Ⅱ receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products:biochemical mechanisms[J]. J Am Soc Nephrol, 2002, 13 (1) :2478-2487.
  • 8CANDIDO R, FORBES JM, THOMAS MC, et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes[J]. Circ Res, 2003,92 (4):785-793.
  • 9FORBES JM ,COOPER ME ,THALLAS V ,et al. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy[J]. Diabetes,2002,51(11) :3274-3283.
  • 10MARX N,WALCHER D,IVANOVA N, et al. Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products[J]. Diabetes, 2004,53 (10) : 2662 - 2668.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部